Galmed Pharmaceuticals Statistics
Share Statistics
Galmed Pharmaceuticals has 2.26M
shares outstanding. The number of shares has increased by -72.43%
in one year.
| Shares Outstanding | 2.26M |
| Shares Change (YoY) | -72.43% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 799 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 96.43K, so 4.27% of the outstanding
shares have been sold short.
| Short Interest | 96.43K |
| Short % of Shares Out | 4.27% |
| Short % of Float | 4.4% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | -0.11 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Galmed Pharmaceuticals.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.42,
with a Debt / Equity ratio of 0.
| Current Ratio | 7.42 |
| Quick Ratio | 7.42 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-2,304,000 |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -72.08% in the
last 52 weeks. The beta is 0.7, so Galmed Pharmaceuticals's
price volatility has been higher than the market average.
| Beta | 0.7 |
| 52-Week Price Change | -72.08% |
| 50-Day Moving Average | 1.77 |
| 200-Day Moving Average | 3.2 |
| Relative Strength Index (RSI) | 38.73 |
| Average Volume (20 Days) | 1,917,818 |
Income Statement
| Revenue | n/a |
| Gross Profit | -31K |
| Operating Income | 7.49M |
| Net Income | -6.91M |
| EBITDA | -6.87M |
| EBIT | -6.9M |
| Earnings Per Share (EPS) | -30.05 |
Full Income StatementBalance Sheet
The company has 4.65M in cash and 0 in
debt, giving a net cash position of 4.65M.
| Cash & Cash Equivalents | 4.65M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -200.47M |
| Total Assets | 18.5M |
| Working Capital | 13.95M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -5.88M
and capital expenditures 0, giving a free cash flow of -5.88M.
| Operating Cash Flow | -5.88M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.88M |
| FCF Per Share | 0 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
